ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
102,381.70
2.32%
S&P 500
5,872.16
-2.95%
Dow Jones
42,326.87
-2.58%
US Dollar vs Yen
156.813
1.37%
Brent Oil
72.885
0.21%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) ニュース

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:PLX
日付受信時刻ニュースソース見出しコード企業名
2024/11/1421 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2024/11/1420 : 57Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2024/11/0607 : 00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
2024/10/2605 : 23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
2024/10/2521 : 27Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2024/09/2506 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2024/09/2506 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2024/08/1420 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2024/08/1419 : 56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2024/05/1806 : 05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:PLXProtalix BioTherapeutics Inc
2024/05/1806 : 00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
2024/05/1020 : 20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2024/05/1019 : 59Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2024/01/0220 : 36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
2023/12/2620 : 56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/11/3018 : 00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
2023/11/0621 : 50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
2023/11/0621 : 22Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/11/0105 : 40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
2023/10/2019 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/10/0406 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1605 : 46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1605 : 45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/09/1219 : 58Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
2023/09/0619 : 50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
2023/08/1805 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:PLX

最近閲覧した銘柄

BIT
I06838
Intesa Sanpaolo
BIT
F36428
Vontobel Financial Produ...
BIT
W7B980
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有